UroGen settles JELMYTO patent litigation with Teva

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/12/2026

1. CRWV
2. SMCI
3. LITE
4. ONON
5. CAVA
6. ETOR
7. NTHI
8. QNT
9. SPY
10. AMC

Go back to UroGen settles JELMYTO patent litigation with Teva
(NASDAQ: URGN) Delayed: 48.11 +1.00 (2.12%)
Previous Close $47.11    52 Week High $ 
Open $47.49    52 Week Low $ 
Day High $48.11    P/E N/A 
Day Low $47.12    EPS $ 
Volume 102,017